## Abstract Head and neck cancers are treated by a combination of surgery, radiotherapy and/or chemotherapy. The clinical success of cisplatinโbased chemotherapy, mostly in combination with 5โFU or a taxane, is however limited by multifactorial intrinsic or acquired resistance. So far, known genes
Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells
โ Scribed by Saki, Mohammad; Toulany, Mahmoud; Rodemann, H. Peter
- Book ID
- 123378173
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 906 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract It has been previously demonstrated that human carcinomas express interleukinโ2 receptor (ILโ2R) ฮฑ, ฮฒ, and ฮณ chains. The ฮฒ and ฮณ chains of ILโ2R have intermediate binding affinity for ILโ2 and are responsible for the intracellular signaling cascades after ILโ2 stimulation. ILโ2Rฮฑ lacks
## Abstract ## BACKGROUND: Recent genetic studies have implicated p53 mutation as a significant risk factor for therapeutic failure in squamous cell carcinoma of the head and neck (SCCHN). However, in a recent metaโanalysis in the literature of p53 from major anatomical subsites (larynx, oral cavi